Talk:Uppsala Monitoring Centre

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Low	This article has been rated as Low-importance on the project's importance scale.

Sweden Low‑importance

	Sweden portal This article is within the scope of WikiProject Sweden, a collaborative effort to improve the coverage of Sweden-related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.SwedenWikipedia:WikiProject SwedenTemplate:WikiProject SwedenSweden
Low	This article has been rated as Low-importance on the project's importance scale.

Remove "benefits" and "effectiveness"

This edit request by an editor with a conflict of interest has now been answered.

In several places, the article claims that the benefits and effectiveness of medicines are part of Uppsala Monitoring Centre's work. This is incorrect.:
Uppsala Monitoring Centre is only concerned with the risks and safety of medicines, i.e. pharmacovigilance. According to WHO, pharmacovigilance can be defined as "... the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem. ":
https://apps.who.int/whocc/Detail.aspx?DfT6Na60S0olEABAP30OCg==^[1]:

AD2000BC (talk) 15:35, 5 December 2024 (UTC)[reply]

Not done It's not clear what changes you want made to the article. Please do this in a "change X to Y" format. Ultraodan (talk) 05:40, 7 January 2025 (UTC)[reply]

Thank you very much for responding!

Please change the first paragraph from "Uppsala Monitoring Centre (UMC), located in Uppsala, Sweden, is the field name for the World Health Organization Collaborating Centre for International Drug Monitoring. UMC works by collecting, assessing and communicating information from member countries' national pharmacovigilance centres in regard to the benefits, harm, effectiveness and risks of drugs." to "Uppsala Monitoring Centre (UMC), is a non-profit foundation working for the safer use of medicines and vaccines. Located in Uppsala, Sweden, UMC is the designated World Health Organization Collaborating Centre for International Drug Monitoring.^[1][2] UMC works by collecting, assessing and communicating information from member countries' national pharmacovigilance centres in regard to the risks of medicines and vaccines."

Please add the following two new References ([1] and [2] in the revised text) to the list of references:

1. About Uppsala Monitoring Centre. https://who-umc.org/about-uppsala-monitoring-centre/

2. WHO Collaborating Centres Global database. https://apps.who.int/whocc/Detail.aspx?DfT6Na60S0olEABAP30OCg==

Please change the third paragraph, second bulletpoint, from "To collect, assess and communicate information from member countries about the benefits, harms and risks of drugs and other substances used in medicine to improve patient therapy and public health worldwide" to "To collect, assess and communicate information from member countries about the risks of drugs and other substances used in medicine to improve patient therapy and public health worldwide" AD2000BC (talk) 10:09, 9 January 2025 (UTC)[reply]

References

^ "WHO Collaborating Centre for International Drug Monitoring". WHO Collaborating Centres Global Database. World Health Organization. Retrieved 5 December 2024.

[1] "WHO Collaborating Centre for International Drug Monitoring". WHO Collaborating Centres Global Database. World Health Organization. Retrieved 5 December 2024.

[1]